News
Norgine on a growth charge again with Theravia takeover deal
Netherlands-based pharma group Norgine has expanded its rare disease portfolio with the acquisition of France's Theravia for an undisclosed sum.
News
US starts the clock ticking on pharma tariffs
The US has launched a national security probe into the national security implications of importing pharmaceuticals, seen as a precursor to tariffs.
News
BMS gets another FDA okay for Opdivo/Yervoy combo
Bristol-Myers Squibb has claimed its second FDA approval in just a few days for its Opdivo/Yervoy combination, this time in liver cancer.
News
Approval moves Columvi earlier in DLBCL treatment pathway
Roche has claimed a first-in-class approval in the EU for Columvi in relapsed/refractory diffuse large B-cell lymphoma (DLBCL).
News
RFK Jr unorthodox vaccine views on show in interview
Robert F Kennedy Jr's controversial views on vaccines were on display this week during an interview that touched on delays to a COVID-19 shot review.
News
Press Releases
Views & Analysis
Editor's Picks
Editor's Picks
